MCID: GLY011
MIFTS: 49

Glycogen Storage Disease Vii malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases, Blood diseases, Liver diseases, Cardiovascular diseases, Muscle diseases, Nephrological diseases, Endocrine diseases

Aliases & Classifications for Glycogen Storage Disease Vii

About this section

Aliases & Descriptions for Glycogen Storage Disease Vii:

Name: Glycogen Storage Disease Vii 51 11 69 12 13
Glycogen Storage Disease Type Vii 11 24 25 53 38 67
Tarui Disease 47 24 25 53 69
Muscle Phosphofructokinase Deficiency 11 47 25 69
Phosphofructokinase Deficiency 24 25 49
Pfkm Deficiency 47 25 69
Gsd Vii 24 25 69
Gsd7 47 25 69
Glycogen Storage Disease Type 7 47 53
Glycogen Storage Disease 7 69 26
Glycogen Storage Disease Due to Muscle Phosphofructokinase Deficiency 53
Glycogenosis Due to Muscle Phosphofructokinase Deficiency 53
 
Gsd Due to Muscle Phosphofructokinase Deficiency 53
Glycogen Storage Disease, Type Vii 11
Phosphofructokinase, Muscle Type 12
Phosphofructokinase Myopathy 11
Glycogenosis Type Vii 53
Glycogenosis Type 7 53
Glycogenosis 7 25
Pfk Deficiency 24
Gsd Type Vii 53
Gsd Type 7 53
Gsd-Vii 69
Gsdvii 24

Characteristics:

Orphanet epidemiological data:

53
glycogen storage disease type vii:
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood

HPO:

63
glycogen storage disease vii:
Inheritance: autosomal recessive inheritance
Onset and clinical course: variable expressivity

Classifications:



External Ids:

OMIM51 232800
Disease Ontology11 DOID:11721
ICD1029 E74.09
MeSH38 D006014
NCIt44 C118437
SNOMED-CT61 234406005, 89597008
Orphanet53 ORPHA371
UMLS via Orphanet68 C0017926
ICD10 via Orphanet30 E74.0
MedGen36 C0017926

Summaries for Glycogen Storage Disease Vii

About this section
NIH Rare Diseases:47 Glycogen storage disease type 7 (GSD7) is an inherited condition in which the body is unable to break down glycogen (a complex sugar) in the muscle cells. Because glycogen is an important source of energy, this can interfere with the normal functioning of muscle cells. The severity of the condition and the associated signs and symptoms vary, but may include muscle weakness and stiffness; painful muscle cramps; nausea and vomiting; and/or myoglobinuria (the presence of myoglobin in the urine) following moderate to strenuous exercise. Symptoms typically resolve with rest. GSD7 is most commonly diagnosed during childhood; however, some affected people may rarely develop symptoms during infancy or later in adulthood. Those who develop the condition during infancy may experience additional symptoms such as hypotonia (poor muscle tone), cardiomyopathy and breathing difficulties that often lead to a shortened lifespan (less than 1 year). This condition is caused by changes (mutations) in the PFKM gene and is inherited in an autosomal recessive manner. There is no specific treatment for GSD7; however, affected people are generally advised to avoid vigorous exercise and high-carbohydrate meals. Last updated: 5/18/2015

MalaCards based summary: Glycogen Storage Disease Vii, also known as glycogen storage disease type vii, is related to pheochromocytoma-islet cell tumor syndrome and glycogen storage disease, and has symptoms including myotonia, skeletal muscle atrophy and jaundice. An important gene associated with Glycogen Storage Disease Vii is PFKM (Phosphofructokinase, Muscle), and among its related pathways are Glycogen Metabolism and Glucagon signaling pathway. Affiliated tissues include liver and skeletal muscle.

UniProtKB/Swiss-Prot:69 Glycogen storage disease 7: A metabolic disorder characterized by exercise intolerance with associated nausea and vomiting, muscle cramping, exertional myopathy and compensated hemolysis. Short bursts of intense activity are particularly difficult. Severe muscle cramps and myoglobinuria develop after vigorous exercise.

Genetics Home Reference:25 Glycogen storage disease type VII (GSDVII) is an inherited disorder caused by an inability to break down a complex sugar called glycogen in muscle cells. A lack of glycogen breakdown interferes with the function of muscle cells.

OMIM:51 Glycogen storage disease VII is an autosomal recessive metabolic disorder characterized clinically by exercise... (232800) more...

Wikipedia:70 Phosphofructokinase deficiency, also known as glycogen storage disease type VII or Tarui\'s disease, is... more...

Related Diseases for Glycogen Storage Disease Vii

About this section

Graphical network of diseases related to Glycogen Storage Disease Vii:



Diseases related to glycogen storage disease vii

Symptoms for Glycogen Storage Disease Vii

About this section

Symptoms by clinical synopsis from OMIM:

232800

Clinical features from OMIM:

232800

Human phenotypes related to Glycogen Storage Disease Vii:

 63 53 (show all 16)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 myotonia63 53 hallmark (90%) Very frequent (99-80%) HP:0002486
2 skeletal muscle atrophy63 53 typical (50%) Frequent (79-30%) HP:0003202
3 jaundice63 HP:0000952
4 cholelithiasis63 HP:0001081
5 muscle weakness63 53 Frequent (79-30%) HP:0001324
6 hemolytic anemia63 HP:0001878
7 reticulocytosis63 HP:0001923
8 gout63 HP:0001997
9 exercise intolerance63 HP:0003546
10 increased total bilirubin63 HP:0003573
11 exercise-induced muscle cramps63 HP:0003710
12 exercise-induced myoglobinuria63 HP:0008305
13 increased muscle glycogen content63 53 Very frequent (99-80%) HP:0009051
14 reduced erythrocyte 2,3-diphosphoglycerate concentration63 HP:0030271
15 anemia53 Very frequent (99-80%)
16 hyperuricemia53 Frequent (79-30%)

UMLS symptoms related to Glycogen Storage Disease Vii:


muscle weakness

Drugs & Therapeutics for Glycogen Storage Disease Vii

About this section

Drugs for Glycogen Storage Disease Vii (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MiglustatapprovedPhase 12172599-27-051634
Synonyms:
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
1,5-Dideoxy-1,5-N-butylimino-D-glucitol
134282-77-2
72599-27-0
AC1L1BHJ
BuDNJ
Butyldeoxynojirimycin
CHEBI:49779
CHEBI:50381
CHEMBL1029
CID51634
D05032
DB00419
HMS2090N20
LS-116261
Miglustat
Miglustat (USAN/INN)
Miglustat [USAN]
Miglustat, Hydrochloride
Miglustatum
N-(N-Butyl)deoxynojirimycin
N-(n-Butyl)deoxynojirimycin
N-(n-butyl)-1,5-dideoxy-1,5-imino-D-glucitol
 
N-Bu-DNJ
N-Butyl deoxynojirimycin
N-Butyl-1-deoxynojirimycin
N-Butyl-DNJ
N-Butyl-deoxynojirimycin
N-Butyldeoxynojirimycin
N-Butylmoranoline
N-butyl-1-deoxynojirimycin
NB-DNJ
NB-dnj
NBV
OGT 918
OGT-918
SC 48334
SC-48334
SC48334
UNII-ADN3S497AZ
Vevesca
Zavesca
Zavesca (TN)
miglustatum
n-Butyl deoxynojirimycin
n-Butyl dnj
nchembio.81-comp12
nchembio850-comp5
2
1-DeoxynojirimycinexperimentalPhase 12619130-96-21374
Synonyms:
(2R,3R,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol
1 deoxynojirimycin
1,5-Dideoxy-1,5-imino-D-glucitol, 9CI
1,5-deoxy-1,5-imino-D-mannitol
1,5-dideoxy-1,5-imino-D-glucitol
1-DEOXY-NOJIRIMYCIN
1-Deoxymannojirimycin
1-Deoxynojirimycin
1-Deoxynojirimycin (DNJ)
1-deoxy-nojirimycin
 
1-deoxynojirimycin
1hxk
1oim
5-amino-1,5-dideoxy-D-glucopyranose
Antibiotic S-GI
D-1-deoxynojirimycin
DNJ
Deoxynojirimycin
Moranoline
NOJ
S-GI
3Hypoglycemic AgentsPhase 15733
4Glycoside Hydrolase InhibitorsPhase 1128
5ImmunoglobulinsPhase 16045
6Cardiac GlycosidesPhase 1148
7AntibodiesPhase 16045
8Anti-HIV AgentsPhase 13100
9Anti-Infective AgentsPhase 121402
10Antiviral AgentsPhase 19732
11Anti-Retroviral AgentsPhase 13232
12
AcetylcholineapprovedEarly Phase 177651-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
13
Somatostatinapproved22938916-34-6, 51110-01-153481605
Synonyms:
growth hormone-inhibiting hormone (GHIH)
 
somatotropin release-inhibiting factor (SRIF)
somatotropin release-inhibiting hormone
14Pharmaceutical Solutions7793
15insulin4524
16Insulin, Globin Zinc4523
17Hormones13979
18Calcium, Dietary5525
19Liver Extracts3868
20Pyridostigmine BromideEarly Phase 125101-26-8
21Cholinesterase InhibitorsEarly Phase 1570
22AnticonvulsantsEarly Phase 12620
23BromidesEarly Phase 1606
24Cholinergic AgentsEarly Phase 13846
25Neurotransmitter AgentsEarly Phase 117734

Interventional clinical trials:

(show all 13)
idNameStatusNCT IDPhase
1The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)RecruitingNCT02432768Phase 2
2Triheptanoin in Mc ArdleNot yet recruitingNCT02919631Phase 2
3VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Patients With Late-Onset Pompe DiseaseNot yet recruitingNCT02898753Phase 1, Phase 2
4A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated ReactionRecruitingNCT02185651Phase 1
5Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 DiabetesCompletedNCT02068638
6Genetic and Family Studies of Inherited Muscle DiseasesCompletedNCT00001331
7Fat and Sugar Metabolism During Exercise in Patients With Metabolic MyopathyRecruitingNCT02635269
8Biomarker for Glycogen Storage DiseasesRecruitingNCT02385162
9Biomarker for Pompe DiseaseRecruitingNCT01457443
10A Pilot Study of Pyridostigmine in Pompe DiseaseRecruitingNCT02357225Early Phase 1
11Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle WeaknessRecruitingNCT02746718
12Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor MutationsRecruitingNCT02023489
13Diet and Exercise in Pompe DiseaseNot yet recruitingNCT02363153Early Phase 1

Search NIH Clinical Center for Glycogen Storage Disease Vii


Cochrane evidence based reviews: glycogen storage disease type vii

Genetic Tests for Glycogen Storage Disease Vii

About this section

Genetic tests related to Glycogen Storage Disease Vii:

id Genetic test Affiliating Genes
1 Glycogen Storage Disease, Type Vii26
2 Glycogen Storage Disease Type Vii24 PFKM

Anatomical Context for Glycogen Storage Disease Vii

About this section

MalaCards organs/tissues related to Glycogen Storage Disease Vii:

35
Liver, Skeletal muscle

Animal Models for Glycogen Storage Disease Vii or affiliated genes

About this section

Publications for Glycogen Storage Disease Vii

About this section

Variations for Glycogen Storage Disease Vii

About this section

UniProtKB/Swiss-Prot genetic disease variations for Glycogen Storage Disease Vii:

69 (show all 11)
id Symbol AA change Variation ID SNP ID
1PFKMp.Arg39LeuVAR_006063rs121918193
2PFKMp.Arg39ProVAR_006064rs121918193
3PFKMp.Arg100GlnVAR_006065rs2228500
4PFKMp.Gly209AspVAR_006066rs767265360
5PFKMp.Asp543AlaVAR_006067rs121918194
6PFKMp.Trp686CysVAR_006068rs121918196
7PFKMp.Arg696HisVAR_006069rs41291971
8PFKMp.Gly57ValVAR_072239
9PFKMp.Ser180CysVAR_072240
10PFKMp.Asp309GlyVAR_072241
11PFKMp.Asp591AlaVAR_072242

Clinvar genetic disease variations for Glycogen Storage Disease Vii:

5
id Gene Variation Type Significance SNP ID Assembly Location
1PFKMPFKM, IVS15DS, G-T, +1SNVPathogenicChr na, -1: -1
2PFKMPFKM, IVS6AS, A-C, -2SNVPathogenicChr na, -1: -1
3PFKMNM_001166686.1(PFKM): c.329G> C (p.Arg110Pro)SNVPathogenicrs121918193GRCh37Chr 12, 48524176: 48524176
4PFKMNM_001166686.1(PFKM): c.1841A> C (p.Asp614Ala)SNVPathogenicrs121918194GRCh37Chr 12, 48535824: 48535824
5PFKMPFKM, IVS5DS, G-A, +1SNVPathogenicChr na, -1: -1
6PFKMNM_001166686.1(PFKM): c.329G> T (p.Arg110Leu)SNVPathogenicrs121918193GRCh37Chr 12, 48524176: 48524176
7PFKMNM_001166686.1(PFKM): c.496C> T (p.Arg166Ter)SNVPathogenicrs121918195GRCh37Chr 12, 48526696: 48526696
8PFKMNM_001166686.1(PFKM): c.2271G> T (p.Trp757Cys)SNVPathogenicrs121918196GRCh37Chr 12, 48538879: 48538879
9PFKMPFKM, 1-BP DEL, 2003CdeletionPathogenicChr na, -1: -1
10PFKMNM_000289.5(PFKM): c.237+1G> ASNVPathogenicrs202143236GRCh37Chr 12, 48525177: 48525177

Expression for genes affiliated with Glycogen Storage Disease Vii

About this section
Search GEO for disease gene expression data for Glycogen Storage Disease Vii.

Pathways for genes affiliated with Glycogen Storage Disease Vii

About this section

Pathways related to Glycogen Storage Disease Vii according to GeneCards Suite gene sharing:

(show all 14)
idSuper pathwaysScoreTop Affiliating Genes
19.8GBE1, PYGM
29.5PFKL, PYGM
3
Show member pathways
9.0PFKL, PFKM, PFKP
4
Show member pathways
9.0PFKL, PFKM, PFKP
5
Show member pathways
9.0PFKL, PFKM, PFKP
6
Show member pathways
9.0PFKL, PFKM, PFKP
7
Show member pathways
9.0PFKL, PFKM, PFKP
8
Show member pathways
9.0PFKL, PFKM, PFKP
99.0PFKL, PFKM, PFKP
10
Show member pathways
8.9GBE1, MGAM, PYGM
11
Show member pathways
8.3GBE1, PFKL, PFKM, PFKP, PYGM
12
Show member pathways
7.8MGAM, PFKL, PFKM, PFKP, PYGM
13
Show member pathways
7.5GBE1, MGAM, PFKL, PFKM, PFKP, PYGM
14
Show member pathways
7.1AMPD3, GBE1, MGAM, PFKL, PFKM, PFKP

GO Terms for genes affiliated with Glycogen Storage Disease Vii

About this section

Cellular components related to Glycogen Storage Disease Vii according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
16-phosphofructokinase complexGO:000594510.3PFKL, PFKM
2extracellular exosomeGO:00700627.5GBE1, MGAM, PFKL, PFKM, PFKP, PYGM
3cytosolGO:00058297.4AMPD3, GBE1, PFKL, PFKM, PFKP, PYGM

Biological processes related to Glycogen Storage Disease Vii according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1glycogen metabolic processGO:000597710.1GBE1, PYGM
2glycolytic process through fructose-6-phosphateGO:006161510.0PFKL, PFKM
3glycogen catabolic processGO:00059809.9PFKM, PYGM
4glycolytic processGO:00060969.5PFKL, PFKM
5protein oligomerizationGO:00512599.5PFKL, PFKM
6fructose 6-phosphate metabolic processGO:00060029.4PFKL, PFKM, PFKP
7canonical glycolysisGO:00616219.4PFKL, PFKM, PFKP

Molecular functions related to Glycogen Storage Disease Vii according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1fructose bindingGO:007006110.1PFKL, PFKM
26-phosphofructokinase activityGO:00038729.6PFKL, PFKM, PFKP
3kinase bindingGO:00199009.5PFKL, PFKM
4carbohydrate bindingGO:00302469.0GBE1, MGAM, PYGM

Sources for Glycogen Storage Disease Vii

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet